Literature DB >> 20942594

Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on the age at onset of neuropsychiatric symptoms in Wilson's disease.

Grazyna Gromadzka1, Anna Członkowska.   

Abstract

ABSTRACT Wilson's disease (WND) is an autosomal recessive copper storage disease characterized with diverse clinical pictures with the hepatic and/or neuropsychiatric symptoms manifesting at variable age. On the basis of the existing knowledge on possible copper-proinflammatory cytokines interactions, we hypothesized that in WND hereditary, over-/underexpression of PC or anti-inflammatory cytokines may have an impact on the course of the disease. We analyzed the clinical manifestations of WND in relationship to polymorphisms within genes for interleukin-1 receptor antagonist (IL1RN intron 2 VNTR polymorphism), interleukin-1α (IL1A G4845T), IL-1β (IL1B C-511T), IL-6 (IL6 G-174C), and tumor necrosis factor (TNF G-308A) in a total sample of 332 patients. The IL1B C-511T and IL1RN VNTR polymorphisms had an impact on copper metabolism parameters. None of the studied gene polymorphisms had effect on the mode of WND manifestation (neuropsychiatric vs. hepatic). Carriership of the IL1RN *2 allele was related to earlier WND onset, especially among patients with neuropsychiatric form of the disease (median 27.5 vs. 32.0 years, p = .003). Because of the crucial modulatory role of IL1ra on IL-1α and IL-1β proinflammatory functions, IL1ra and its interactions may play a role in the pathogenesis of the neurodegenerative process in WND; our results need to be replicated, possibly in different ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20942594     DOI: 10.3109/00207454.2010.523131

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  7 in total

1.  Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease.

Authors:  T Litwin; G Gromadzka; J Samochowiec; A Grzywacz; A Członkowski; A Członkowska
Journal:  JIMD Rep       Date:  2012-07-06

Review 2.  Canine Models for Copper Homeostasis Disorders.

Authors:  Xiaoyan Wu; Peter A J Leegwater; Hille Fieten
Journal:  Int J Mol Sci       Date:  2016-02-04       Impact factor: 5.923

Review 3.  Currently Clinical Views on Genetics of Wilson's Disease.

Authors:  Chen Chen; Bo Shen; Jia-Jia Xiao; Rong Wu; Sarah Jane Duff Canning; Xiao-Ping Wang
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

4.  Cardiac assessment in Wilson's disease patients based on electrocardiography and echocardiography examination.

Authors:  Małgorzata Buksińska-Lisik; Tomasz Litwin; Tomasz Pasierski; Anna Członkowska
Journal:  Arch Med Sci       Date:  2017-09-07       Impact factor: 3.318

Review 5.  Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications.

Authors:  Grażyna Gromadzka; Beata Tarnacka; Anna Flaga; Agata Adamczyk
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

6.  Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson's disease.

Authors:  Grażyna Gromadzka; Diana Wierzbicka; Tomasz Litwin; Adam Przybyłkowski
Journal:  Biometals       Date:  2021-02-08       Impact factor: 2.949

7.  Concordance rates of Wilson's disease phenotype among siblings.

Authors:  Grzegorz Chabik; Tomasz Litwin; Anna Członkowska
Journal:  J Inherit Metab Dis       Date:  2013-06-18       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.